Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
source: pixabay.com
In 2021, Alyssa, who is now thirteen years old, and her family were told that she had acute lymphoblastic leukemia. Alyssa did not respond to either the standard leukemia…
Continue Reading
Alyssa is the First Person to Receive a New Treatment for Acute Lymphoblastic Leukemia
According to a recent article featured in Biospace, researchers found substantial evidence of a biochemical correction after treating an eleven-year girl for Gaucher Disease. This is the first pediatric case…
Continue Reading
Promising Gene Therapy Seeking Approval to Treat Advanced Gaucher Disease
source: unsplash.com
Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…
Continue Reading
Compassion Corner: How Can Technology Help Us Be Compassionate to Ourselves?
source: pixabay.com
Researchers at Brown University, in collaboration with an MIT research team, discovered a method of penetrating the blood-brain barrier (BBB) in mice and delivering medication to treat lethal tumors…
Continue Reading
Researchers Discover a Method to Cross the Blood-Brain Barrier and Treat Lethal Tumors
Have you ever wondered how a rare disease can take control of a person’s life? The deteriorating health, being unable to receive an accurate diagnosis, and more importantly finding an…
Continue Reading
Improving a Rare Disease Patient’s Access to Specialty-Pharmaceuticals and Gene Therapies
Genetech recently announced the FDA’s approval of Tecentriq to treat alveolar soft part sarcoma (ASPS) pediatric and adult patients over the age of two. This first-ever treatment has been developed…
Continue Reading
The FDA Approves New Therapy for Rare Alveolar Soft Part Sarcoma (ASPS)
source: pixabay.com
An announcement via PR NewsWire by NeuroSense Therapeutics based in Cambridge, Massachusetts carried the results of its multi-dose study of PrimeC to treat amyotrophic lateral sclerosis (ALS) Expectations are…
Continue Reading
NeuroSense Announces Results of its Study of PrimeC to Treat ALS
source
When we look at statistics that show thirty million people in the U.S. has one of seven thousand rare diseases, they may not seem rare. However, when we realize that…
Continue Reading
The Future of Specialty Drugs
The CDC lists lung cancer as the third most common type of cancer in the United States with the highest death rate. Estimates are given of 2.2 million patients worldwide…
Continue Reading
The FDA Approves New Combination Treatment for Non-Small Cell Lung Cancer
Medscape Medical News reports that results have been received from the OCCLURANDOM Phase 2 trial which is the first randomized trial investigating the antitumor effect of the peptide receptor radionuclide…
Continue Reading
Pancreatic Cancer Patients in the Phase 2 OCLURANDOM Trial See a Twelve Month Progression-Free Survival of 80 Percent
Dr. Jose Sandoval-Sus, an oncologist at the Moffitt Cancer Center, was recently interviewed with Medscape regarding his review which was published in the October 2022 Current Oncology Reports. The new…
Continue Reading
Mantle Cell Lymphoma: Not Yet Curable, But This Doctor Believes the Future is Bright
Inside Precision Medicine recently featured an article focusing on biomarkers that suggest the likelihood of drugs called checkpoint inhibitors to “backfire” during melanoma treatment. Checkpoint inhibitors are one of the…
Continue Reading
Biomarkers Found for Hyper-Progression of Melanoma after Immunotherapy
source: pixabay.com
Previous research presents strong evidence favoring shared decision-making after a medical diagnosis. One major improvement has been designing treatment plans that include a good deal of the patient’s goals and…
Continue Reading
Shared Treatment Decision-Making for DLBCL Patients
source: pixabay.com
The loss of axons (nervous system wiring) has been responsible for various neurodegenerative diseases such as peripheral neuropathies, Parkinson’s disease, glaucoma, and amyotrophic lateral sclerosis (ALS). According to a…
Continue Reading
Two Studies Lead to Possible Therapeutic Approach for Neurodegenerative Diseases
In the ongoing search for prevention and a cure for Alzheimer’s Disease (AD), a study was conducted at Colorado’s Anschutz Medical Campus. The researchers found that memory and learning are…
Continue Reading
A Gene Has Been Discovered That Could Prevent Alzheimer’s Disease
source: unsplash.com
According to the National Institute of Neurological Disorders and Stroke, chorea is defined as involuntary movements that are caused by a neurological disorder. It is one of a group of…
Continue Reading
Results of a Three-Year Study Support AUSTEDO to Treat Chorea Related to Huntington’s Disease
source: pixabay.com
A team headed by Harvard Medical School scientists has taken steps to unravel a dementia that surfaces early in a person’s life. The study, published in Neuroscience News and Nature…
Continue Reading
Frontotemporal Dementia: The Latest Discoveries
source: pixabay.com
Atlanta, Georgia’s Linseigh Green received a diagnosis of necrotizing enterocolitis (NEC) when she was born. She was sent to the hospital’s NICU only two weeks after her birth. Linseigh’s…
Continue Reading
Necrotizing Enterocolitis: Defying a Dangerous Prognosis
source: pixabay.com
The XV International Conference on Rare Diseases-D'Genes was streamed in sixteen countries in April 2022. Juan Carrión, D’Genes President, announced that the theme for 2022 is Equity and Rights…
Continue Reading
A Rare Disease Should Not Mean More Isolation and Less Support
source: unsplash.com
Researchers have known about EGCG for decades. It is a plant compound called catechin found in green tea that may prevent disease and protect cells from damage. According to…
Continue Reading
This Molecule Can Get Rid of Amyloid Tangles Linked to Alzheimer’s Disease
Reports by experts find approximately five to ten percent of cancers may be traced to hereditary genetic changes (germline mutations) which exist in each and every cell. Instead, research in…
Continue Reading
Gene Alterations in Rare Cancers Could Allow for Earlier Diagnosis of Hereditary Cancers
Lyme disease is often either misdiagnosed or completely undiagnosed. According to Inside Precision Medicine's report, researchers at Mount Sinai’s Icahn School recently teamed with Johns Hopkins University to improve diagnostics…
Continue Reading
Researchers Identify Genes Linked to Long-Term Lyme Disease
According to a recent article in Medical Life Sciences, the radiation dose rates used by the new FLASH radiotherapy are over three hundred times more intense than conventional treatments. The…
Continue Reading
New FLASH Radiotherapy Has Potential to Kill Tumors Faster and With Fewer Side Effects
Scientists at California’s La Jolla Institute are conducting a study that is the forerunner of a clinical that will be investigating human antibodies. The new vaccine will be pitted against…
Continue Reading
An All-out Attack on the Lassa Virus That Kills 300,000 West Africans Each Year
Verge Genomics, based in San Francisco is one of a series of biotechs that have entered into a new era using AI in drug discovery. The company is backed by…
Continue Reading
Will This Novel Drug That Utilizes AI Succeed in Having an Impact on ALS When so Many Others Have Failed?